A Barth

Author PubWeight™ 86.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995 2.70
2 Mechanism for transition from initial to stable cell-cell adhesion: kinetic analysis of E-cadherin-mediated adhesion using a quantitative adhesion assay. J Cell Biol 1996 2.20
3 Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001 1.94
4 Ace/Fgf8 is required for forebrain commissure formation and patterning of the telencephalon. Development 2000 1.50
5 Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995 1.41
6 [Chronic anemia and abdominal pain as a sequela of lead poisoning]. Dtsch Med Wochenschr 2001 1.38
7 Isolated infarcts of the pons. Neurology 1996 1.25
8 The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 1987 1.24
9 A clinical physiologic study of hydroxyethyl starch. Surg Gynecol Obstet 1970 1.22
10 Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J Neurosci 1995 1.16
11 Reaction-induced infrared difference spectroscopy for the study of protein reaction mechanisms. Biochemistry 2001 1.12
12 Stress and the menstrual cycle: relevance of cycle quality in the short- and long-term response to a 5-day endotoxin challenge during the follicular phase in the rhesus monkey. J Clin Endocrinol Metab 1998 1.10
13 [Studies on the purification and characterization of dipeptidyl aminopeptidase IV]. Acta Biol Med Ger 1974 1.08
14 Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 2003 1.06
15 Effects of cerebral perfusion pressure and increased fraction of inspired oxygen on brain tissue oxygen, lactate and glucose in patients with severe head injury. Acta Neurochir (Wien) 2003 1.05
16 P(3)-[2-(4-hydroxyphenyl)-2-oxo]ethyl ATP for the rapid activation of the Na(+),K(+)-ATPase. Biophys J 2000 1.01
17 Imaging tumors with peptide-based radioligands. Q J Nucl Med 2001 1.00
18 Measles outbreak in an asylum-seekers' shelter in Germany: comparison of the implemented with a hypothetical containment strategy. Epidemiol Infect 2011 0.98
19 Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 1993 0.98
20 Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome. J Child Neurol 2001 0.97
21 Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity. Eur J Biochem 1996 0.95
22 Structural changes of the sarcoplasmic reticulum Ca(2+)-ATPase upon nucleotide binding studied by fourier transform infrared spectroscopy. Biophys J 2000 0.94
23 Diffusion-weighted MRI for monitoring neurovascular interventions. Neuroradiology 2000 0.93
24 Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum. Biochim Biophys Acta 1988 0.93
25 Vaccine therapy for malignant melanoma. CA Cancer J Clin 1996 0.93
26 Side-chain protonation and mobility in the sarcoplasmic reticulum Ca2+-ATPase: implications for proton countertransport and Ca2+ release. Biophys J 2007 0.92
27 Internal artificial vagina (IAV) to assess breeding behavior of young Bos taurus and Bos indicus bulls. Anim Reprod Sci 2011 0.91
28 Fourier transform infrared (FTIR) spectroscopic investigation of the nicotinic acetylcholine receptor (nAChR). Investigation of agonist binding and receptor conformational changes by flash-induced release of 'caged' carbamoylcholine. FEBS Lett 1992 0.90
29 Diagnostic management of orthostatic intolerance in the workplace. Int Arch Occup Environ Health 2002 0.90
30 A case of hydrocephalus occlusus presenting as bipolar disorder. Acta Psychiatr Scand 2005 0.90
31 Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol Chem Hoppe Seyler 1991 0.89
32 Nocturnal positional lumboischialgia: presenting symptom of lumbar spinal tumours. J Neurol 2008 0.88
33 Magnetic resonance angiography with ultrashort echo times reduces the artefact of aneurysm clips. Neuroradiology 2002 0.87
34 Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clin Res Cardiol 2007 0.87
35 Cases of community-acquired meticillin-resistant Staphylococcus aureus in an asylum seekers centre in Germany, November 2010. Euro Surveill 2011 0.86
36 The conformation around the peptide bond between the P1- and P2-positions is important for catalytic activity of some proline-specific proteases. Biochim Biophys Acta 1983 0.85
37 Digital image analysis of self-similar cell profiles. Int J Biomed Comput 1994 0.85
38 Dipeptidylpeptidase IV--inactivation with N-peptidyl-O-aroyl hydroxylamines. J Enzyme Inhib 1988 0.84
39 Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. Biochem J 1984 0.84
40 Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases. In Vivo 1991 0.84
41 Role of dipeptidyl peptidase IV in uptake of peptide nitrogen from beta-casomorphin in rabbit renal BBMV. Am J Physiol 1987 0.84
42 Granuloma formation and occlusion of an unruptured aneurysm after wrapping. Acta Neurochir (Wien) 2007 0.83
43 N,O-diacylhydroxylamines as enzyme-activated inhibitors for serine proteases. Pharmazie 1983 0.83
44 Lead exposure levels and duration of exposure absence predict neurobehavioral performance. Int Arch Occup Environ Health 2005 0.83
45 [Kinetics of dipeptidyl-peptidase IV]. Acta Biol Med Ger 1978 0.83
46 Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability. J Nucl Med 1995 0.82
47 Analysis of a putative voltage-gated prokaryotic potassium channel. Eur J Biochem 2001 0.82
48 Influence of magnesium on the intestinal absorption of lead. Environ Res 1976 0.82
49 Derivatives of beta-casomorphins with high analgesic potency. Peptides 1984 0.82
50 Structural changes of sarcoplasmic reticulum Ca(2+)-ATPase upon Ca2+ binding studied by simultaneous measurement of infrared absorbance changes and changes of intrinsic protein fluorescence. Biochim Biophys Acta 1994 0.81
51 Excretion of lithium by kidney, bile and faeces in rats of different ages. Arch Int Pharmacodyn Ther 1982 0.81
52 Reactions between dipeptidyl peptidase IV and diacyl hydroxylamines: mechanistic investigations. J Enzyme Inhib 1989 0.81
53 A model of the active site of dipeptidyl peptidase IV predicted by comparative molecular field analysis and molecular modelling simulations. Int J Pept Protein Res 1995 0.80
54 Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance. Int Arch Occup Environ Health 2005 0.80
55 Purification and characterization of prolyl endopeptidase from pig brain. Biol Chem Hoppe Seyler 1990 0.79
56 Health consequences of an intravenous injection of metallic mercury. Int Arch Occup Environ Health 2002 0.79
57 Temporal expression, polar distribution and transition of an epitope domain in the perinuclear theca during mouse spermatogenesis. J Cell Sci 1990 0.79
58 Depth of side-chain pocket in the S2 subsite of dipeptidyl peptidase IV. Biochim Biophys Acta 1985 0.79
59 The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes. Biomed Biochim Acta 1985 0.79
60 Clinical validation of an automated vessel-segmentation software of the extracranial-carotid arteries based on 3D-MRA: a prospective study. J Neuroradiol 2008 0.79
61 Urinary excretion of delta aminolevulinic acid after discontinuance of therapy for lead poisoning. A test for adequacy of therapy. J Pediatr 1972 0.79
62 Cerebral revascularization model in a swine. Acta Neurochir Suppl 2005 0.79
63 Characterization and augmentation of CD4+ cytotoxic T cell lines against melanoma. Cancer Immunol Immunother 1994 0.79
64 [New aspects in the surgical treatment of hyperparathyroidism]. Schweiz Med Wochenschr 1987 0.79
65 Aminopeptidases in the circumventricular organs of the mouse brain: a histochemical study. Neuroscience 1992 0.79
66 Potent and selective inactivation of cysteine proteinases with N-peptidyl-O-acyl hydroxylamines. Biochem J 1989 0.79
67 A new consistent model explaining structure (conformation)-activity relationships of opiates with mu-selectivity. Drug Des Discov 1993 0.78
68 Contribution of the apparent diffusion coefficient in perilesional edema for the assessment of brain tumors. J Neuroradiol 2008 0.78
69 [alpha-Aminoacylpeptide hydrolases (EC 3.4.11) and dipeptide hydrolases (EC 3.4.13) in microorganisms and seedlings]. Pharmazie 1976 0.78
70 Structure-activity relationships of cyclic beta-casomorphin-5 analogues. Peptides 1992 0.78
71 Glycine causes increased excitability and neurotoxicity by activation of NMDA receptors in the hippocampus. Exp Neurol 1997 0.78
72 Potent and selective inactivation of proteinases with N-peptidyl-O-acylhydroxylamines. Biochim Biophys Acta 1989 0.78
73 Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures. Brain Res 1995 0.78
74 Peptidyl ammonium methyl ketones as substrate analog inhibitors of proline-specific peptidases. J Enzyme Inhib 1993 0.77
75 Degradation of beta-casomorphin-5 by proline-specific-endopeptidase (PSE) and post-proline- cleaving-enzyme (PPCE). Comparative studies of the beta-casomorphin-5 cleavage by dipeptidyl-peptidase IV. Pharmazie 1982 0.77
76 [Dipeptidyl peptidase activities in various organs of the Wistar rat]. Pharmazie 1983 0.77
77 The effect of parity of the dam on sexual maturation, serum concentrations of metabolic hormones and the response to luteinizing hormone releasing hormone in bull calves. Reprod Domest Anim 2010 0.77
78 [DP-IV activities in tissues from WKY and SH rats]. Pharmazie 1982 0.77
79 [Diagnostic value of the enzyme dipeptidyl peptidase IV (DP IV) in abdominal cancers]. Arch Geschwulstforsch 1986 0.77
80 Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signalling function in T cells. Immunobiology 1993 0.77
81 Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000. Braz J Infect Dis 2003 0.77
82 Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002. Clin Microbiol Infect 2004 0.77
83 Myeloperoxidase levels predict executive function. Int J Sports Med 2012 0.77
84 Estrogen sulfamates: a new approach to oral estrogen therapy. Reprod Fertil Dev 2001 0.77
85 Cyclosporin-A-induced lipid peroxidation in human liver microsomes and its influence on cytochrome P-450. Eur J Clin Invest 1991 0.77
86 Age-related dynamics of constitutive cytokine transcription levels of feline monocytes. Exp Gerontol 2005 0.76
87 Diabetic wound healing and the case for supplemental treatment with topical insulin. J Foot Surg 1982 0.76
88 Molecular interactions in intermediate and transition states in the self-stimulated inhibition of enzymes. Pharmazie 1988 0.76
89 Diffusion-weighted and perfusion-weighted MR of cerebral vasospasm. Acta Neurochir Suppl 2001 0.76
90 Contamination of highly purified human serum cholinesterase by dipeptidyl peptidase IV causing hydrolysis of substance P. Pharmazie 1986 0.76
91 Stepwise degradation of the hexapeptide Met-Ala-Ser-Pro-Phe-Ala by dipeptidyl peptidase IV. Biomed Biochim Acta 1987 0.76
92 Judging models in QSAR- and LFE-like studies if there are no replications: correlation of dipeptidyl peptidase IV hydrolytic activities of L-Alanyl-L-alanine phenylamides. Pharmazie 1982 0.76
93 CT and MRI in acute hemorrhagic stroke. Cerebrovasc Dis 2000 0.76
94 Two males with childhood disintegrative disorder: a prospective 14-year outcome study. Dev Med Child Neurol 1998 0.75
95 [Stereotactically-guided microsurgery in cerebral processes]. Schweiz Med Wochenschr 1993 0.75
96 Comparative quantitative assessment of GnRH- and LH-receptor mRNA expression in the urinary tract of sexually intact and spayed female dogs. Theriogenology 2007 0.75
97 Iatrogenic rupture of a cerebral aneurysm on the feeding artery of an arteriovenous malformation. Interv Neuroradiol 2001 0.75
98 [The connection between the influence on urease activity and the pharmacological effect of some drugs with cardiac and coronary activity]. Arch Int Pharmacodyn Ther 1972 0.75
99 [Contribution of nuclear magnetic resonance imaging in the diagnosis and pathogenesis of brain stem and cerebellar infarction]. Rev Med Suisse Romande 1993 0.75
100 Synthesis and cloning of a human beta-casomorphin-5 gene. Nucleic Acids Symp Ser 1987 0.75
101 [Competitive antagonism between isoprenalin and adrenolytic agents toward urease]. Arch Int Pharmacodyn Ther 1973 0.75
102 [Modelling of enzyme-active substance interactions]. Pharmazie 1975 0.75
103 Circulatory activity of dopamine-dipeptide compounds. Biomed Biochim Acta 1988 0.75
104 Ionic composition of bile in young and adult rats. Z Versuchstierkd 1984 0.75
105 [Structure-activity relationship in the enzymatic hydrolysis of dipeptide aryl amides by dipeptidyl peptidase IV]. Acta Biol Med Ger 1980 0.75
106 Age dependence of hepatic transport in control and phenobarbital-pretreated rats. Life Sci 1979 0.75
107 Are Z-Arg-Gly-Phe-Phe-Leu-MNA and Z-Arg-Gly-Phe-Phe-Pro-MNA suitable substrates for the demonstration of cathepsin D activity? Histochemistry 1988 0.75
108 [Efficiency of a new instrument: the Jet-Floss for the elimination of dental plaque]. J Parodontol 1990 0.75
109 [Effect of progesterone and phenylbutazone on bile flow and bile acid excretion in male Wistar rats]. Acta Biol Med Ger 1978 0.75
110 ["Step-by-step" mechanism of the hydrolysis of oligopeptide-4-(phenylazo)-phenylamides by microsomal aminopeptidase from swine kidney cortex (EC 3.4.1.2)]. Pharmazie 1974 0.75
111 Intraductal breast carcinoma: experiences from the Breast Center in Van Nuys, California. Recent Results Cancer Res 1996 0.75
112 Centralized narcotic accounting improves income and saves time. Mod Hosp 1966 0.75
113 Extra- and intracellular potassium concentration and prostaglandin production of skin fibroblasts grown from patients with Bartter's syndrome. Prostaglandins Leukot Med 1986 0.75
114 [Home care services yesterday, today, tomorrow]. Z Krankenpfl 1973 0.75
115 Influence of phenobarbital, chlorpromazine, progesterone and phenylbutazone on the biliary cholesterol excretion in rats. Acta Biol Med Ger 1980 0.75
116 [Validity of post-proline splitting dipeptidyl aminopeptidase activities in the cerebrospinal fluid for neurologic and psychiatric diagnosis]. Psychiatr Neurol Med Psychol (Leipz) 1986 0.75
117 [Primary therapy of advanced ovarian carcinoma: current status and perspectives]. Gynakol Geburtshilfliche Rundsch 1996 0.75
118 [A quantitative structure-activity analysis based on quantum statistical derivations]. Pharmazie 1975 0.75
119 Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: A modified type of structure-activity equations. Pharmazie 1979 0.75
120 Quantitative structure-activity relationships in phytotoxic piperidinoacetanilides. Environ Qual Saf Suppl 1975 0.75
121 [Effect of metyrapone on bile flow and bile acid excretion in Wistar rats]. Acta Biol Med Ger 1979 0.75
122 [Synthesis and enzymatic degradation of beta-casomorphin-5 (author's transl)]. Pharmazie 1982 0.75
123 Fertilizing characteristics of bovine sperm with flattened or indented acrosomes. Anim Reprod Sci 2001 0.75
124 [Synthesis of cyclic and cyclically branched tachykinin partial sequences. 1. Synthesis of the homodet-cyclic eledoisin(6-11)-hexapeptide]. Pharmazie 1985 0.75
125 Infradian biorhythms of enzymuria in man? J Clin Chem Clin Biochem 1988 0.75
126 [Synthesis of cyclic and non-cyclic tachykinin partial sequences. 2. Synthesis of the homocyclic substance P(6-11) hexapeptide]. Pharmazie 1985 0.75
127 Comparison of the effects of cholestyramine and aluminium hydroxide on the biliary bile acid excretion in rats. An experimental model for the depletion of bile acids in bile. Acta Biol Med Ger 1980 0.75
128 [Structure-activity relationships of acetylcholinesterase inhibitors with carbamate structure]. Pharmazie 1978 0.75
129 Extended investigation of the substrate specificity of dipeptidyl peptidase IV from pig kidney. Biol Chem Hoppe Seyler 1991 0.75
130 [ANP plasma level as a marker of disordered diastolic ventricular function in patients with collagenoses]. Z Kardiol 1991 0.75
131 Hippurate as a source of renal and hepatic ammoniagenesis in different species. Contrib Nephrol 1997 0.75
132 [On amino acid-4-(phenylazo)-phenyl derivatives. XI. L-Alanine-4-(phenylazo)-phenylamide as a substrate for the colorimetric activity determinations of amino acid aryl amidases in serum]. Acta Biol Med Ger 1966 0.75
133 [The behavior of dipeptidyl peptidase IV in PUVA therapy of patients with psoriasis]. Dermatol Monatsschr 1989 0.75
134 [Activity of alanine aminotransferase and sorbitol dehydrogenase in rat serum following loading with indocyanine green]. Z Med Lab Diagn 1981 0.75
135 Is the analgesic activity of epibatidine caused by a chemical reaction with the morphine opioid receptor? SAR QSAR Environ Res 1993 0.75
136 Comparative study on the antithrombotic effects of a synthetic thrombin inhibitor and of heparin in animal models. Biomed Biochim Acta 1983 0.75
137 [Vascular risk factors in patients with ophthalmoplegia]. Med Klin (Munich) 1990 0.75
138 Synthetic wound dressings--evaluation of interactions with epithelial and dermal cells in vitro. Skin Pharmacol 1996 0.75
139 [Mechanisms of degradation of carbamate herbicides]. Pharmazie 1969 0.75
140 [Urease]. Pract Otorhinolaryngol (Basel) 1971 0.75
141 Choleric potencies of some bile acids and their effect on biliary excretion of eosin in the rat. Acta Biol Med Ger 1980 0.75
142 [Current problems in active susbtance research. 13. Selected problems and developmental trends of the phytopharmacology]. Pharmazie 1977 0.75
143 The influence of bile acids on biliary excretion of indocyanine green in rats of different ages. Acta Biol Med Ger 1981 0.75
144 [Current problems in drug research. 10. Scientific and economic aspects of drug research]. Pharmazie 1976 0.75
145 Cytochrome P450 (P450) isoforms expression, P450 concentration, monooxygenase activities, reactive oxygen species formation, lipid peroxidation, and glutathione content in wild catch carp and tench liver--influence of a two weeks exposure to phenobarbital. Exp Toxicol Pathol 2001 0.75
146 [Somatoform disorders without findings--modern syndromes]. Internist (Berl) 2002 0.75
147 Studies on the fatty acid synthesis of the perfused cirrhotic liver. Exp Pathol 1984 0.75
148 [Renal dipeptidylpeptidase IV excretion in drug-induced kidney changes]. Z Urol Nephrol 1986 0.75
149 [Arterial blood pressure in chronic venous insufficiency]. Zentralbl Phlebol 1971 0.75
150 Influence of lithium on biliary electrolyte and bile acid excretion in young and adult rats. Acta Physiol Hung 1985 0.75
151 [Theoretical aspects of ascertaining parameters of action of biologically active compounds]. Pharmazie 1976 0.75
152 On the selectivity of aryl hydrocarbon hydroxylase induction after 3-methylcholanthrene pretreatment. Acta Biol Med Ger 1975 0.75
153 [Determination of dipeptidyl-peptidase IV in biological materials]. J Clin Chem Clin Biochem 1986 0.75
154 Nonopioid effects of beta-casomorphin-5 in guinea pig heart: alterations to the beta-adrenoceptor-G-protein complex and inhibition of myocardial responses to isoproterenol. Peptides 1991 0.75
155 [Quantitative chemical data as factors in a quantitative structure-activity analysis]. Pharmazie 1976 0.75
156 The construct of canalization and Tourette syndrome. Percept Mot Skills 1997 0.75
157 [Application of dipeptidylpeptidase IV in formation of the peptide bond]. Pharmazie 1989 0.75
158 [Studies of the consecutive hydrolysis of dipeptidyl-4-(phenylazo)-phenylamides by an aminopeptidase from Brassica napus]. Acta Biol Med Ger 1979 0.75
159 Kinetic investigation of the hydrolysis of aminoacyl p-nitroanilides by dipeptidyl peptidase IV from human and pig kidney. Biochim Biophys Acta 1984 0.75
160 [The activity of dipeptidyl peptidase IV in various organs and tissues of the rat and its possible relation with substance P metabolism]. Pharmazie 1981 0.75
161 pH-dependence of catalytic constants of the enzyme reaction--some remarks. Pharmazie 1981 0.75
162 [Treatment of severe idiopathic cold-agglutinin diseases using interferon-alpha 2b]. Schweiz Med Wochenschr 1994 0.75
163 Mathematical model of dose-activity relationships. Environ Qual Saf Suppl 1975 0.75
164 Angiographically undetected aneurysm in the neck remnant after endovascular coiling. Acta Neurochir (Wien) 2003 0.75
165 Interaction of liposomal incorporated vitamin D3-analogues and human keratinocytes. J Drug Target 1994 0.75
166 Total colectomy and ileostomy. Nurs Mirror 1978 0.75
167 Similarities of the substrate cleavage catalyzed by proline specific endopeptidase and dipeptidyl peptidase IV. Pharmazie 1984 0.75
168 [Reaction of alpha-amino acids with quinonesulfonic acids]. Pharmazie 1976 0.75
169 Effects of beta-casomorphin in isolated heart preparations. Pharmazie 1988 0.75
170 A new mechanism in serine proteases catalysis exhibited by dipeptidyl peptidase IV (DP IV)--Results of PM3 semiempirical thermodynamic studies supported by experimental results. Eur J Biochem 1996 0.75
171 [Bile flow and bile acid excretion in male Wistar rats (Jena) of different ages]. Z Versuchstierkd 1977 0.75
172 Photosynthetically active suspension cultures of potato spindle tuber viroid infected tomato cells as tools for studying viroid - host cell interaction. Plant Cell Rep 1993 0.75
173 [Extrapolation of animal studies to reactions in man]. Pharmazie 1983 0.75
174 The probable conformation of substrates recognized by dipeptidyl-peptidase IV and some aspects of the catalytic mechanism derived from theoretical investigations. J Comput Aided Mol Des 1992 0.75
175 [Coccidioidomycosis--differential diagnosis of lung infiltrates with peripheral eosinophilia]. Dtsch Med Wochenschr 1989 0.75
176 Spectroscopic analysis of [Trp3]-beta-casomorphin analogs. Comparative structure conformation-activity studies. Int J Pept Protein Res 1991 0.75
177 Beta-casomorphin affects fast and slow action potentials in ventricular myocardium. Pharmazie 1985 0.75
178 [Enzymatic peptide synthesis--a review]. Pharmazie 1990 0.75
179 [Dipeptidylpeptidase IV activity in human lymphocytes in hepatobiliary diseases]. Gastroenterol J 1990 0.75
180 CoMFA investigations on two series of artificial peptide inhibitors of the serine protease thermitase. Synthesis of an inhibitor of predicted greater potency. Int J Pept Protein Res 1995 0.75
181 Persistent hypoglossal artery found incidentally. JBR-BTR 2005 0.75
182 [Current problems in the research on active substances. 12. Mechanism of action and structure-activity relationships of herbicides of the urea, carbamate, amide and triazine types]. Pharmazie 1976 0.75
183 Influence of new estrogens on liver transport function in rats. Arch Int Pharmacodyn Ther 1986 0.75
184 Deproceptin, Tyr-Pro-Phe-D-Pro-NH2, another casomorphin with remarkable analgesic action. Acta Biol Med Ger 1982 0.75
185 [Mechanism of action and substitute effects of herbicides of urea-, carbamate, amide- and triazine type]. Pharmazie 1969 0.75
186 Dipeptidyl-peptidase IV, chemistry, biochemistry and physiological aspects. Pharmazie 1981 0.75
187 [A new approach to the analysis of enzyme-active principle interactions]. Pharmazie 1976 0.75
188 [Effect of phenobarbital and chlorpromazine on bile flow and bile acid excretion in male Wistar rats]. Acta Biol Med Ger 1978 0.75
189 Surgical treatment of suprasellar arachnoid cyst. Eur Neurol 1994 0.75
190 Michigan Hospital Association observes 50th year of challenge. Mich Med 1969 0.75
191 [Determination of distribution coefficients in a series of biologically active piperidinoacetanilides and their relations to tabulated pi values]. Pharmazie 1978 0.75
192 HAMOG: molecular graphics program for chemistry, biochemistry, molecular biology and enzyme research. J Mol Graph 1991 0.75
193 Opiate receptor binding affinities of some D-amino acid substituted beta-casomorphin analogs. Peptides 1986 0.75
194 Age-dependence of succinate dehydrogenase (SDH) in rat liver and its inducibility after barbital and phenylbutazone pretreatment. Physiol Bohemoslov 1977 0.75
195 [Catalytic mechanism of dipeptidyl-peptidase IV]. Acta Biol Med Ger 1978 0.75
196 Effects of beta-casomorphin on 3H-ouabain binding to guinea pig heart membranes. Pharmazie 1986 0.75
197 Influence of xenobiotics on bile flow and bile composition in rats--methodological approach. Exp Pathol 1990 0.75
198 [Management of pain in neonatology]. Soins Gynecol Obstet Pueric Pediatr 1992 0.75
199 [Theory of phytodrug-receptor-reciprocal action. A model on molecular level]. Pharmazie 1970 0.75
200 Influence of drugs on bile acid excretion. Arch Toxicol Suppl 1978 0.75
201 [Early diagnostic criteria of ankylosing spondylitis in patients with acute anterior uveitis]. Fortschr Ophthalmol 1990 0.75
202 Reaction of dipeptidylpeptidase IV with substrate-analogous azapeptides. J Enzyme Inhib 1991 0.75
203 Follow-up of perfusion defects in pulmonary perfusion scanning after pulmonary embolism: are we too careless? Nucl Med Commun 2002 0.75
204 [Isolation and characterization of dipeptidylpeptidase IV from human seminal plasma]. Biomed Biochim Acta 1986 0.75
205 [NMR studies of piperidinoacetanilides with pharmacologic activity]. Pharmazie 1976 0.75
206 Induction of parturition in Zebu-cross recipients carrying in vitro-produced Bos indicus embryos. Theriogenology 2007 0.75
207 Hepatic elimination kinetics of organic anions in rats: developmental aspects and influence of phenobarbital. Arch Int Pharmacodyn Ther 1986 0.75